Cargando…

CMV immune evasion and manipulation of the immune system with aging

Human cytomegalovirus (HCMV) encodes numerous proteins and microRNAs that function to evade the immune response and allow the virus to replicate and disseminate in the face of a competent innate and acquired immune system. The establishment of a latent infection by CMV, which if completely quiescent...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Sarah E., Redeker, Anke, Arens, Ramon, van Baarle, Debbie, van den Berg, Sara P. H., Benedict, Chris A., Čičin-Šain, Luka, Hill, Ann B., Wills, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505894/
https://www.ncbi.nlm.nih.gov/pubmed/28647908
http://dx.doi.org/10.1007/s11357-017-9986-6
_version_ 1783249479893254144
author Jackson, Sarah E.
Redeker, Anke
Arens, Ramon
van Baarle, Debbie
van den Berg, Sara P. H.
Benedict, Chris A.
Čičin-Šain, Luka
Hill, Ann B.
Wills, Mark R.
author_facet Jackson, Sarah E.
Redeker, Anke
Arens, Ramon
van Baarle, Debbie
van den Berg, Sara P. H.
Benedict, Chris A.
Čičin-Šain, Luka
Hill, Ann B.
Wills, Mark R.
author_sort Jackson, Sarah E.
collection PubMed
description Human cytomegalovirus (HCMV) encodes numerous proteins and microRNAs that function to evade the immune response and allow the virus to replicate and disseminate in the face of a competent innate and acquired immune system. The establishment of a latent infection by CMV, which if completely quiescent at the level of viral gene expression would represent an ultimate in immune evasion strategies, is not sufficient for lifelong persistence and dissemination of the virus. CMV needs to reactivate and replicate in a lytic cycle of infection in order to disseminate further, which occurs in the face of a fully primed secondary immune response. Without reactivation, latency itself would be redundant for the virus. It is also becoming clear that latency is not a totally quiescent state, but is characterized by limited viral gene expression. Therefore, the virus also needs immune evasion strategies during latency. An effective immune response to CMV is required or viral replication will cause morbidity and ultimately mortality in the host. There is clearly a complex balance between virus immune evasion and host immune recognition over a lifetime. This poses the important question of whether long-term evasion or manipulation of the immune response driven by CMV is detrimental to health. In this meeting report, three groups used the murine model of CMV (MCMV) to examine if the contribution of the virus to immune senescence is set by the (i) initial viral inoculum, (ii) inflation of T cell responses, (iii) or the balance between functionally distinct effector CD4+ T cells. The work of other groups studying the CMV response in humans is discussed. Their work asks whether the ability to make immune responses to new antigens is compromised by (i) age and HCMV carriage, (ii) long-term exposure to HCMV giving rise to an overall immunosuppressive environment and increased levels of latent virus, or (iii) adapted virus mutants (used as potential vaccines) that have the capacity to elicit conventional and unconventional T cell responses.
format Online
Article
Text
id pubmed-5505894
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55058942017-07-25 CMV immune evasion and manipulation of the immune system with aging Jackson, Sarah E. Redeker, Anke Arens, Ramon van Baarle, Debbie van den Berg, Sara P. H. Benedict, Chris A. Čičin-Šain, Luka Hill, Ann B. Wills, Mark R. GeroScience Conference Proceedings Human cytomegalovirus (HCMV) encodes numerous proteins and microRNAs that function to evade the immune response and allow the virus to replicate and disseminate in the face of a competent innate and acquired immune system. The establishment of a latent infection by CMV, which if completely quiescent at the level of viral gene expression would represent an ultimate in immune evasion strategies, is not sufficient for lifelong persistence and dissemination of the virus. CMV needs to reactivate and replicate in a lytic cycle of infection in order to disseminate further, which occurs in the face of a fully primed secondary immune response. Without reactivation, latency itself would be redundant for the virus. It is also becoming clear that latency is not a totally quiescent state, but is characterized by limited viral gene expression. Therefore, the virus also needs immune evasion strategies during latency. An effective immune response to CMV is required or viral replication will cause morbidity and ultimately mortality in the host. There is clearly a complex balance between virus immune evasion and host immune recognition over a lifetime. This poses the important question of whether long-term evasion or manipulation of the immune response driven by CMV is detrimental to health. In this meeting report, three groups used the murine model of CMV (MCMV) to examine if the contribution of the virus to immune senescence is set by the (i) initial viral inoculum, (ii) inflation of T cell responses, (iii) or the balance between functionally distinct effector CD4+ T cells. The work of other groups studying the CMV response in humans is discussed. Their work asks whether the ability to make immune responses to new antigens is compromised by (i) age and HCMV carriage, (ii) long-term exposure to HCMV giving rise to an overall immunosuppressive environment and increased levels of latent virus, or (iii) adapted virus mutants (used as potential vaccines) that have the capacity to elicit conventional and unconventional T cell responses. Springer International Publishing 2017-06-24 /pmc/articles/PMC5505894/ /pubmed/28647908 http://dx.doi.org/10.1007/s11357-017-9986-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Conference Proceedings
Jackson, Sarah E.
Redeker, Anke
Arens, Ramon
van Baarle, Debbie
van den Berg, Sara P. H.
Benedict, Chris A.
Čičin-Šain, Luka
Hill, Ann B.
Wills, Mark R.
CMV immune evasion and manipulation of the immune system with aging
title CMV immune evasion and manipulation of the immune system with aging
title_full CMV immune evasion and manipulation of the immune system with aging
title_fullStr CMV immune evasion and manipulation of the immune system with aging
title_full_unstemmed CMV immune evasion and manipulation of the immune system with aging
title_short CMV immune evasion and manipulation of the immune system with aging
title_sort cmv immune evasion and manipulation of the immune system with aging
topic Conference Proceedings
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505894/
https://www.ncbi.nlm.nih.gov/pubmed/28647908
http://dx.doi.org/10.1007/s11357-017-9986-6
work_keys_str_mv AT jacksonsarahe cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT redekeranke cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT arensramon cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT vanbaarledebbie cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT vandenbergsaraph cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT benedictchrisa cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT cicinsainluka cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT hillannb cmvimmuneevasionandmanipulationoftheimmunesystemwithaging
AT willsmarkr cmvimmuneevasionandmanipulationoftheimmunesystemwithaging